A previous study found that NT5DC2 inhibits the tumor sphere formation ability and cell viability of glioblastoma stem cells by downregulating Fyn expression, thus indicating that NT5DC2 also interacts with other proteins and participates in cellular activities other than purine-nucleotide metabolism21. The gene discussed is NT5DC2; the disease is glioblastoma.